NCT00498706

Brief Summary

This study will compare the effectiveness of telephone versus face-to-face administration of cognitive behavioral therapy in treating people with depression.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
325

participants targeted

Target at P50-P75 for phase_3 depression

Timeline
Completed

Started Dec 2007

Typical duration for phase_3 depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 10, 2007

Completed
5 months until next milestone

Study Start

First participant enrolled

December 1, 2007

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

July 17, 2013

Completed
Last Updated

July 17, 2013

Status Verified

July 1, 2013

Enrollment Period

4.4 years

First QC Date

July 8, 2007

Results QC Date

August 20, 2012

Last Update Submit

July 15, 2013

Conditions

Keywords

Depressive Disorder, MajorCognitive Behavioral TherapyPsychotherapyTelemedicinePrimary Care

Outcome Measures

Primary Outcomes (4)

  • Attrition (Number of Therapy Sessions Attended)

    Number of therapy sessions attended was collected. At the end of treatment, the total number of sessions attended by each patient was collected.

    Post treatment, up to 18 weeks

  • Number of Participants Who Dropped Out of Therapy

    Using the number of therapy sessions attended, we categorized patients into: 1. those who discontinued treatment before session 18, and those who completed session 18. 2. those who discontinued before Session 5, and those who continued.

    Post treatment, up to 18 weeks

  • Patient Health Questionnaire (PHQ)-9

    Measures depression on a 9 - item scale. Scores range from 0-27, with 0 being no symptoms. A difference of 5 or more points on the PHQ-9 is considered a clinically meaningful response to treatment.

    Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6 post-treatment follow-up

  • Depression, as Assessed by Hamilton Depression Rating Scale(Ham-D)

    Ham-D indicates Hamilton Depression Rating Scale,range is 0 to 52. A score of 0 means the best outcome with no depression symptoms reported, and a score of 52 is the worse outcome with highest level of depression reported. A difference of 3 points on the Hamilton scale has been identified as clinically significant.

    Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6, 9, and 12 of follow-up

Secondary Outcomes (1)

  • Health-related Quality of Life (SF-36V), Patient Satisfaction (Satisfaction Index - Mental Health), and Therapeutic Alliance (Working Alliance Inventory - Short Form)

    Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6, 9, and 12 of follow-up

Study Arms (2)

Telephone-administered CBT

EXPERIMENTAL

Participants will receive telephone-administered cognitive behavioral therapy.

Behavioral: Telephone-administered cognitive behavioral therapy (T-CBT)

Face-to-face CBT

ACTIVE COMPARATOR

Participants will receive face-to-face cognitive behavioral therapy.

Behavioral: Face-to-face administered CBT (FtF-CBT)

Interventions

Over 18 weeks, participants will receive eighteen 45-minute sessions of T-CBT administered by a therapist. Participants will undergo telephone-administered sessions twice a week for 2 weeks, once a week for 12 weeks, and once every 2 weeks for the last 4 weeks. Participants will be taught ways to modify thoughts and behaviors that contribute to their depression and ways to maintain the lifestyle changes that they have made.

Telephone-administered CBT

Over 18 weeks, participants will receive eighteen 45-minute sessions of FtF-CBT administered by a therapist. Participants will undergo face-to-face administered sessions twice a week for 2 weeks, once a week for 12 weeks, and once every 2 weeks for the last 4 weeks. Participants will be taught ways to modify thoughts and behaviors that contribute to their depression and ways to maintain the lifestyle changes that they have made.

Face-to-face CBT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Has a current diagnosis of major depressive disorder
  • Has a primary care physician at Northwestern University in Illinois, or one of a number of approved community clinics in Chicago.
  • Resides in Illinois
  • Has a telephone
  • Speaks and reads English

You may not qualify if:

  • Hearing, voice, or visual impairment
  • Meets criteria for dementia
  • Diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, current substance abuse, or other condition for which participation in a clinical trial of psychotherapy may be either inappropriate or dangerous
  • Currently receiving individual psychotherapy or planning to receive psychotherapy during the treatment phase of the study
  • Planning to be out of town or unavailable for treatment for 4 weeks or more during the scheduled treatment time
  • Recent history of suicide attempts or is severely suicidal
  • Depression determined to be primarily of an organic etiology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern University

Chicago, Illinois, 60611, United States

Location

Related Publications (1)

  • Mohr DC, Ho J, Duffecy J, Reifler D, Sokol L, Burns MN, Jin L, Siddique J. Effect of telephone-administered vs face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients: a randomized trial. JAMA. 2012 Jun 6;307(21):2278-85. doi: 10.1001/jama.2012.5588.

MeSH Terms

Conditions

DepressionDepressive Disorder, Major

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorDepressive DisorderMood DisordersMental Disorders

Results Point of Contact

Title
Dr. David C. Mohr
Organization
Northwestern University

Study Officials

  • David C. Mohr, PhD

    Northwestern University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 8, 2007

First Posted

July 10, 2007

Study Start

December 1, 2007

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

July 17, 2013

Results First Posted

July 17, 2013

Record last verified: 2013-07

Locations